Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics Receives Clinical Trial Application Approval For Two Studies

March 23 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * READY TO INITIATE RECRUITMENT IN BOTH STUDIES AS SOON AS
CURRENT
SITUATION REGARDING COVID-19 ALLOWS
    * JTA-004 TRIAL HAS BEEN APPROVED BY REGULATORY AUTHORITIES
IN
DENMARK, AND ALLOB BY BELGIAN REGULATORY AUTHORITIES
    * JTA-004 TRIAL HAS BEEN APPROVED BY REGULATORY AUTHORITIES
IN
DENMARK, AND ALLOB BY BELGIAN REGULATORY AUTHORITIES
    * STUDY IS EXPECTED TO ENROL APPROXIMATELY 178 PATIENTS IN
APPROXIMATELY 40 SITES IN UP TO 7 EUROPEAN COUNTRIES
    * STUDY EXPECTS TO ENROL 676 PATIENTS WITH MILD TO MODERATE
SYMPTOMATIC KNEE OSTEOARTHRITIS

Source text for Eikon:  ID:nGNE5qBGhf 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Biosenic SA

See all news